Present to Chinese investors and industrial parks, form partnerships, receive funding
APRIL 12-14, 2022
Jiangsu Industrial Technology Research Institute (JITRI) is seeking project companies with innovative drugs and medical device products with independent IP.
is calling for applications!
Life science companies who are accepted into the CUBIO Life Science Funding Program will receive assistance getting a branch of their business set up in China.
· Start-up grant
· Equity investment
· Three years loan support
· Local housing subsidy
Initial Funding Support
3-month incubation training
30-day Sponsored China Bootcamp
China Focus® brings together investors, pharma leaders and innovators from China and around the world for an exclusive partnering event designed to inspire, educate and foster cross-border investment and collaboration in leading biopharma innovations. Since 2018 China Focus has been held in Philadelphia, Boston, San Francisco, Germany, and Vienna. Previous events attracted more than 1700+ participating attendees, 130+ presenting companies, and 600+ projects worldwide. It has become the most important brand activity for cross border collaboration between China and the rest of the world.
Following the successful China [email protected] Francisco，we received a vast amount of positive feedback and increasing interest from Chinese companies and companies worldwide. Under the impact of COVID-19, China Focus® goes virtual to bring together investors, pharma leaders, and innovators from China and around the world.
China Focus® Virtual focuses on 1-on-1 meetings, featured company presentations, and panel discussions to better connect entrepreneurs globally with Chinese companies.
Subscribe to receive upcoming China Focus event notifications
China Focus Virtual October
Schedule 1-on-1 meetings with preferred partners by online partnering system
Connect with Renowned Chinese investors
VP Business and Corporate Development, Sorrento Therapeutics, Inc.
Director of Strategic Development, Feldan Therapeutics
CEO, Sensus Healthcare
CEO, Virometix AG
Acting CFO, RNP Therapeutics
Personally speaking, having the event as a virtual event makes it much easier for companies in Europe to attend, rather than having to travel to attend in person. My goals are very much driven towards forging closer links with Chinese pharma companies who are seeking new early-stage opportunities in Europe, and I certainly see China FOCUS as a great opportunity to support this.
IDACO Consulting Limited